A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 15 350 KRW -5.6% Market Closed
Market Cap: 344.4B KRW
Have any thoughts about
AprilBio Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one AprilBio Co Ltd stock under the Base Case scenario is 16 435.49 KRW. Compared to the current market price of 15 350 KRW, AprilBio Co Ltd is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
16 435.49 KRW
Undervaluation 7%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
AprilBio Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for AprilBio Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about AprilBio Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about AprilBio Co Ltd

Provide an overview of the primary business activities
of AprilBio Co Ltd.

What unique competitive advantages
does AprilBio Co Ltd hold over its rivals?

What risks and challenges
does AprilBio Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AprilBio Co Ltd.

Provide P/S
for AprilBio Co Ltd.

Provide P/E
for AprilBio Co Ltd.

Provide P/OCF
for AprilBio Co Ltd.

Provide P/FCFE
for AprilBio Co Ltd.

Provide P/B
for AprilBio Co Ltd.

Provide EV/S
for AprilBio Co Ltd.

Provide EV/GP
for AprilBio Co Ltd.

Provide EV/EBITDA
for AprilBio Co Ltd.

Provide EV/EBIT
for AprilBio Co Ltd.

Provide EV/OCF
for AprilBio Co Ltd.

Provide EV/FCFF
for AprilBio Co Ltd.

Provide EV/IC
for AprilBio Co Ltd.

Show me price targets
for AprilBio Co Ltd made by professional analysts.

What are the Revenue projections
for AprilBio Co Ltd?

How accurate were the past Revenue estimates
for AprilBio Co Ltd?

What are the Net Income projections
for AprilBio Co Ltd?

How accurate were the past Net Income estimates
for AprilBio Co Ltd?

What are the EPS projections
for AprilBio Co Ltd?

How accurate were the past EPS estimates
for AprilBio Co Ltd?

What are the EBIT projections
for AprilBio Co Ltd?

How accurate were the past EBIT estimates
for AprilBio Co Ltd?

Compare the revenue forecasts
for AprilBio Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AprilBio Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AprilBio Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of AprilBio Co Ltd compared to its peers.

Compare the P/E ratios
of AprilBio Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing AprilBio Co Ltd with its peers.

Analyze the financial leverage
of AprilBio Co Ltd compared to its main competitors.

Show all profitability ratios
for AprilBio Co Ltd.

Provide ROE
for AprilBio Co Ltd.

Provide ROA
for AprilBio Co Ltd.

Provide ROIC
for AprilBio Co Ltd.

Provide ROCE
for AprilBio Co Ltd.

Provide Gross Margin
for AprilBio Co Ltd.

Provide Operating Margin
for AprilBio Co Ltd.

Provide Net Margin
for AprilBio Co Ltd.

Provide FCF Margin
for AprilBio Co Ltd.

Show all solvency ratios
for AprilBio Co Ltd.

Provide D/E Ratio
for AprilBio Co Ltd.

Provide D/A Ratio
for AprilBio Co Ltd.

Provide Interest Coverage Ratio
for AprilBio Co Ltd.

Provide Altman Z-Score Ratio
for AprilBio Co Ltd.

Provide Quick Ratio
for AprilBio Co Ltd.

Provide Current Ratio
for AprilBio Co Ltd.

Provide Cash Ratio
for AprilBio Co Ltd.

What is the historical Revenue growth
over the last 5 years for AprilBio Co Ltd?

What is the historical Net Income growth
over the last 5 years for AprilBio Co Ltd?

What is the current Free Cash Flow
of AprilBio Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for AprilBio Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
AprilBio Co Ltd

Current Assets 85.4B
Cash & Short-Term Investments 60.8B
Receivables 22.5B
Other Current Assets 2.1B
Non-Current Assets 13B
Long-Term Investments 11B
PP&E 1.3B
Intangibles 421.3m
Other Non-Current Assets 286.5m
Current Liabilities 22B
Accrued Liabilities 49.8m
Other Current Liabilities 22B
Non-Current Liabilities 137.7m
Long-Term Debt 112.2m
Other Non-Current Liabilities 25.5m
Efficiency

Earnings Waterfall
AprilBio Co Ltd

Revenue
20.7B KRW
Operating Expenses
-7.7B KRW
Operating Income
13B KRW
Other Expenses
-2.3B KRW
Net Income
10.7B KRW

Free Cash Flow Analysis
AprilBio Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

AprilBio Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive ROE
Positive 3-Year Average ROIC
Negative 3-Year Average ROE
39/100
Profitability
Score

AprilBio Co Ltd's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

AprilBio Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
87/100
Solvency
Score

AprilBio Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
AprilBio Co Ltd

Wall Street analysts forecast AprilBio Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 29 070 KRW with a low forecast of 24 240 KRW and a high forecast of 34 650 KRW.

Lowest
Price Target
24 240 KRW
58% Upside
Average
Price Target
29 070 KRW
89% Upside
Highest
Price Target
34 650 KRW
126% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for AprilBio Co Ltd?

Click here to dive deeper.

Dividends

AprilBio Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for AprilBio Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

AprilBio Co Ltd

Country

Korea

Industry

Biotechnology

Market Cap

333.9B KRW

Dividend Yield

0%

Description

AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.

Contact

GANGWON-DO
Chuncheon
602, B Dong, College of Biomedical Science, 1, Kangwondaehak-gil
+82332536486
www.aprilbio.com

IPO

2022-07-28

Employees

27

Officers

Chief Executive Officer
Sang-Hoon Cha
CFO, Head of Business Management Division & Director of Administration Division
Jin-Taek Kim
CTO & Head of Research & Planning Division
Moo Yong Song
CSO
Seung Goo Kang
CDO and Director of R&D Division
Jae Heung Lee

See Also

Discover More
What is the Intrinsic Value of one AprilBio Co Ltd stock?

The intrinsic value of one AprilBio Co Ltd stock under the Base Case scenario is 16 435.49 KRW.

Is AprilBio Co Ltd stock undervalued or overvalued?

Compared to the current market price of 15 350 KRW, AprilBio Co Ltd is Undervalued by 7%.

Back to Top